Traduction de «breast screening » (Français → Néerlandais) :

TERMINOLOGIE

anomalie au screening anténatal de la mère
bevindingen bij prenataal onderzoek, abnormaal

TRADUCTIONS EN CONTEXTE

49. Miller Ab TTBCJWC. The Canadian National Breast Screening Study-1: breast cancer mortality after 11 to 16 years of follow-up.
50. Miller Ab TTBCJWC. The Canadian National Breast Screening Study-1: breast cancer mortality after 11 to 16 years of follow-up.

28. Law J, Faulkner K, Young KC. Risk factors for induction of breast cancer by X-rays and their implications for breast screening.
27. Law J, Faulkner K, Young KC. Risk factors for induction of breast cancer by X-rays and their implications for breast screening.

20. Miller AB, To T, Baines CJ, Wall C. The Canadian National Breast Screening Study-1: breast cancer mortality after 11 to 16 years of follow-up.
19. Miller AB, To T, Baines CJ, Wall C. The Canadian National Breast Screening Study-1: breast cancer mortality after 11 to 16 years of follow-up.

Ces deux publications se basent sur les données du NHS Breast Screening Programme (NHSBSP).
Deze twee publicaties baseren zich op de gegevens van het NHS Breast Screening Programme (NHSBSP).

27. Heyes GJ, Mill AJ, Charles MW. Enhanced biological effectiveness of low energy X-rays and implications for the UK breast screening programme.
26. Heyes GJ, Mill AJ, Charles MW. Enhanced biological effectiveness of low energy X-rays and implications for the UK breast screening programme.

29. Law J, Faulkner K. Concerning the relationship between benefit and radiation risk, and cancers detected and induced, in a breast screening programme.
28. Law J, Faulkner K. Concerning the relationship between benefit and radiation risk, and cancers detected and induced, in a breast screening programme.

17. Miller A, Baines C, Wall C. Canadian National Breast Screening Study-2: 13-year results of a randomized trial in women aged 50-59 years.
16. Miller A, Baines C, Wall C. Canadian National Breast Screening Study-2: 13-year results of a randomized trial in women aged 50-59 years.

European Guidelines for quality assurance in breast cancer screening and diagnosis, fourth edition European Commission (2006).
European guidelines for quality assurance in breast cancer screening and diagnosis, fourth edition. European Commission (2006).

Le programme suit les recommandations du «European Guidelines for quality assurance in breast cancer screening and diagnosis ».
Het programma is in overeenstemming met de aanbevelingen van de “European Guidelines for quality assurance in breast cancer screening and diagnosis”.

Application Presentation: Symposium A web-based Support System for the belgian Breast Cancer Screening Program (.Powerpoint) by Eddy Husson, Informatique Médicale et Biostatistique, Université de Liège (B)
Application Presentation: A web-based Support System for the belgian Breast Cancer Screening Program(.Powerpoint) by Eddy Husson, Informatique Médicale et Biostatistique, Université de Liège (B)